8-K: Semler Scientific's Q2 2025 Preliminary Results Highlight Significant Bitcoin Gains and Capital Raise Progress

Semler Scientific reported preliminary unaudited Q2 2025 financial results, including an anticipated $90.5 million unrealized gain from Bitcoin holdings and progress on its $500 million at-the-market offering.

Summary

• Preliminary unaudited revenues for the second quarter ended June 30, 2025, are anticipated to be between $8.1 million and $8.3 million.
• Preliminary unaudited operating expenses for the second quarter ended June 30, 2025, are anticipated to be between $10.1 million and $10.5 million, which includes approximately $2.0 million of non-cash stock compensation and depreciation.
• An unrealized gain from the change in fair value of Bitcoin holdings since March 31, 2025, is approximately $90.5 million.
• As of July 2, 2025, Bitcoin holdings totaled 4,636 Bitcoins, acquired for an aggregate of $430.0 million at an average purchase price of $92,753 per Bitcoin.
• The market value of Bitcoin holdings as of July 2, 2025, was $508.4 million, based on the Coinbase exchange price.
• Cash, restricted cash, and cash equivalents as of June 30, 2025, are approximately $13.6 million.
• Under its at-the-market (ATM) offering program, Semler Scientific issued and sold 4,116,735 shares of common stock for aggregate net proceeds of approximately $156.6 million as of July 2, 2025.
• Total basic shares issued and outstanding as of July 2, 2025, were 13,788,405.
• Between June 4, 2025, and July 2, 2025, 187 Bitcoin were acquired for $20.0 million, at an average price of $106,906 per Bitcoin, using proceeds from the ATM offering.
• The BTC Yield was 29.0% year-to-date through July 2, 2025.

Sentiment

Score: 7

Explanation: The company reported a substantial unrealized gain from its Bitcoin holdings and successfully raised significant capital through its ATM offering, which are strong positives. However, preliminary operating expenses exceed revenues, indicating an underlying operational loss, and the Bitcoin strategy introduces considerable volatility risk.

Positives

• Reported a significant preliminary unrealized gain of approximately $90.5 million from its Bitcoin holdings, indicating a successful treasury strategy.
• Successfully executed a portion of its ATM offering, raising approximately $156.6 million in net proceeds, demonstrating effective capital market access.
• Increased its total Bitcoin holdings to 4,636 BTC, reinforcing its commitment to the Bitcoin treasury strategy.
• Achieved a strong BTC Yield of 29.0% year-to-date through July 2, 2025, highlighting the performance of its Bitcoin investment.

Negatives

• Preliminary operating expenses of $10.1 million to $10.5 million are higher than anticipated revenues of $8.1 million to $8.3 million, suggesting an operating loss for the quarter before the impact of Bitcoin gains.
• The company's financial performance is increasingly exposed to the inherent volatility of Bitcoin prices, which could lead to significant fluctuations in reported gains or losses.

Risks

• Preliminary unaudited financial information is subject to change due to the completion of financial closing procedures and interim review processes.
• Risks related to the financial close process, including potential differences between preliminary and final results.
• Risks inherent with settlement of government investigations and negotiating terms with multiple parties (general risk mentioned, no specific investigation detailed).
• Risks related to borrowing funds, including changing interest rates and credit markets.
• Volatility in Bitcoin price, which can significantly impact the value of the company's Bitcoin holdings and reported gains/losses.
• Other risks related to the Bitcoin treasury strategy.
• Risks associated with the company's core healthcare business.
• General risk factors detailed in the company's filings with the Securities and Exchange Commission.

Future Outlook

Semler Scientific anticipates reporting preliminary unaudited financial information for the second quarter ended June 30, 2025, including revenues, operating expenses, and an unrealized gain from Bitcoin holdings. The company continues to execute its at-the-market (ATM) offering and Bitcoin acquisition strategy. Forward-looking statements are subject to various risks, including those related to the financial close process, potential government investigations, borrowing funds, and the inherent volatility of Bitcoin.

Management Comments

• Semler Scientific maintains a dashboard on its website, www.semlerscientific.com, as a disclosure channel to provide broad, non-exclusionary distribution of information regarding its Bitcoin holdings to the public.
• Semler Scientific intends to use this website dashboard as a means of complying with its disclosure obligations under Regulation FD.
• Semler Scientific uses BTC Yield as a KPI to help assess the performance of its strategy of acquiring Bitcoin in a manner Semler Scientific believes is accretive to stockholders.
• Semler Scientific believes this KPI can be used to supplement an investor's understanding of Semler Scientific's decision to fund the purchase of Bitcoin by issuing additional shares of its common stock or instruments convertible to common stock.

Industry Context

Semler Scientific, primarily a healthcare technology company, is increasingly adopting a Bitcoin treasury strategy, which is a notable divergence from typical corporate treasury management practices within the healthcare sector. This positions it uniquely among its healthcare peers and aligns it more with companies like MicroStrategy that have significant Bitcoin holdings. The use of an at-the-market (ATM) offering to fund Bitcoin purchases is a specific strategy to leverage capital markets for cryptocurrency acquisition, a method not commonly seen in traditional healthcare companies.

Comparison to Industry Standards

• The strategy of holding a significant portion of treasury assets in Bitcoin is highly unconventional for a healthcare technology company, contrasting sharply with the conservative cash and short-term investment strategies typical of most companies in the medical device or diagnostic industry.
• Compared to companies like MicroStrategy, which has pioneered a corporate Bitcoin treasury strategy, Semler Scientific's approach is similar in its embrace of Bitcoin as a primary treasury asset, though MicroStrategy's scale of Bitcoin holdings is significantly larger.
• The reported BTC Yield of 29.0% YTD through July 2, 2025, indicates a strong return on its Bitcoin investment, which would be considered exceptional compared to traditional fixed-income or cash management returns.
• The ATM offering is a standard capital raising mechanism, but its specific use to fund Bitcoin acquisitions is unique within the healthcare sector.

Corporate Governance

Stakeholder Impact

• Shareholders face potential for significant gains or losses due to the volatility of Bitcoin prices, which now heavily influences the company's financial results.
• Shareholders experienced dilution from the issuance of 4,116,735 shares under the ATM offering.
• Investors are provided with a new dedicated disclosure channel (Bitcoin Dashboard) for real-time information on Bitcoin holdings and related key performance indicators, enhancing transparency.

Next Steps

• Finalize full financial results for the second quarter ended June 30, 2025.
• Continue to use the website dashboard for broad disclosure of Bitcoin holdings information.
• Potentially continue to issue and sell common stock under the ATM offering program up to the $500.0 million limit.
• Continue the strategy of acquiring and holding Bitcoin as part of its treasury management.

Key Dates

Recommendation

Keywords

Semler Scientific, SMLR, Bitcoin, BTC, cryptocurrency, Q2 2025, preliminary financial results, 8-K filing, ATM offering, capital raise, treasury strategy, healthcare technology, medical devices, financial reporting, unrealized gain, operating expenses, revenue